Resurgence of Eating Disorders with Olanzapine.
Λέξεις-κλειδιά
Αφηρημένη
BACKGROUND
Olanzapine is commonly utilized in palliative care for the treatment of nausea, and a known side effect of olanzapine is increased appetite. Olanzapine is also known to cause re-emergence of eating disorders (EDs) in patients utilizing olanzapine for its antipsychotic effects. It is unclear to what extent this may also occur in patients with serious/life-limiting illness.
RESULTS
We present a case of a 70-year-old female with recurrent ovarian cancer and a history of bulimia nervosa (BN) that developed resurgence of her BN after initiation of olanzapine for cancer-associated nausea. Her BN resolved with reducing the dose of olanzapine.
CONCLUSIONS
It is important to recognize that recurrence of EDs can occur when using olanzapine in the palliative care setting.
